Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.720
-0.190 (-4.86%)
At close: Jan 30, 2026, 4:00 PM EST
3.650
-0.070 (-1.88%)
After-hours: Jan 30, 2026, 6:54 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $32.41 million as of January 30, 2026. Its market cap has increased by 489.27% in one year.
Market Cap
32.41M
Enterprise Value
29.52M
1-Year Change
489.27%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $32.41M, a decrease of -31.63%. That is a compound annual growth rate of -7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 21.20M | -5.36% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 34.17M |
| Reviva Pharmaceuticals Holdings | 34.17M |
| TuHURA Biosciences | 32.49M |
| Skye Bioscience | 32.38M |
| Outlook Therapeutics | 32.32M |
| Werewolf Therapeutics | 32.11M |
| Kyntra Bio | 31.88M |
| Dyadic International | 31.52M |